June 2025
1. DASGUPTA D, Tripathi A, Griffard-Smith R, Yellapu N, et al
   Therapeutic potential of NRF2 activating drug RTA-408 in suppressing T cell effector responses and inflammatory bowel disease.
   J Immunol. 2025 Jun 16:vkaf117. doi: 10.1093.
   

   >> Share

   
   March 2025
2. GALAN C, Lu G, Gill R, Li D, et al
   RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination.
   J Immunol. 2025;214:460-471.
   

   >> Share

   
   July 2024
3. HU D, Li Y, Wang X, Zou H, et al
   Palmitoylation of NLRP3 Modulates Inflammasome Activation and Inflammatory Bowel Disease Development.
   J Immunol. 2024 Jul 1:ji2300241. doi: 10.4049/jimmunol.2300241.
   

   >> Share

   
   June 2024
4. DANIELSON SM, Lefferts AR, Norman E, Regner EH, et al
   Myeloid Cells and Sphingosine-1-Phosphate Are Required for TCRalphabeta Intraepithelial Lymphocyte Recruitment to the Colon Epithelium.
   J Immunol. 2024;212:1843-1854.
   

   >> Share

   
   April 2024
5. CHENG MI, Hong L, Bustillos C, Chen B, et al
   Cutting Edge: Hypoxia Sensing by the Histone Demethylase UTX (KDM6A) Limits Colitogenic CD4+ T Cells in Mucosal Inflammation.
   J Immunol. 2024;212:1069-1074.
   

   >> Share

   
   September 2023
6. LOU Y, Jiang S, Song M, Wang H, et al
   Epithelial TIPE1 Protein Guards against Colitis by Inhibiting TNF-alpha-Mediated Inflammation.
   J Immunol. 2023;211:874-884.
   

   >> Share

   
   June 2023
7. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
   Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
   J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share